Hospital
Ahn Emerus Westmoreland LLC
Ahn Emerus Westmoreland LLC was paid $2.59M by Medicaid between Jun 2020 and Dec 2024, across 65 billing codes. Its largest line is 99283, emergency room visit (moderate) — 32% of everything it billed.
33Billing provider infoAHN EMERUS WESTMORELAND LLC
PITTSBURGH, PA 15227
PITTSBURGH, PA 15227
33aNPI1215598156assigned 06/21/2019
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.59M
24GClaims79,035
24DCodes billed65
24AFirst – last monthJun 2020 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#83 of 154
Median peer was paid$2.82M
This provider vs. median0.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 4,391 | $93K | |
| 2021 | 26,540 | $678K | |
| 2022 | 16,225 | $535K | |
| 2023 | 18,054 | $664K | |
| 2024incomplete | 13,825 | $615K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 32% | 10,278 | 10,062 | $829K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 27% | 5,996 | 5,824 | $701K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 20% | 3,493 | 3,370 | $508K |
| 87428 | 4.7% | 5,044 | 4,972 | $123K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.9% | 2,447 | 2,351 | $49K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.6% | 290 | 281 | $42K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.1% | 592 | 571 | $29K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,866 | 1,781 | $25K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,365 | 6,060 | $24K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 463 | 453 | $19K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 573 | 549 | $15K |
| 82550 | <1% | 3,057 | 2,946 | $14K |
53 more codes
| 80051 | <1% | 3,031 | $14K | |
| 80053 | Comprehensive metabolic panel | <1% | 1,849 | $13K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,175 | $13K |
| 82565 | <1% | 3,029 | $13K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,463 | $11K |
| 84520 | <1% | 3,018 | $11K | |
| 81003 | <1% | 4,368 | $9K | |
| 82947 | <1% | 3,274 | $8K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 602 | $8K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 166 | $8K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,474 | $8K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 845 | $7K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 94 | $7K |
| 84484 | <1% | 922 | $6K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 299 | $6K |
| 81025 | <1% | 2,024 | $5K | |
| 82977 | <1% | 778 | $5K | |
| 71045 | Radiologic examination, chest; single view | <1% | 835 | $5K |
| 84460 | <1% | 794 | $4K | |
| 84450 | <1% | 794 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 504 | $4K |
| 82247 | <1% | 787 | $4K | |
| 84075 | <1% | 787 | $3K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 16 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 227 | $3K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 172 | $3K |
| 83605 | <1% | 503 | $3K | |
| 82150 | <1% | 799 | $3K | |
| 84155 | <1% | 787 | $2K | |
| 85379 | <1% | 326 | $2K | |
| 73610 | <1% | 159 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 814 | $2K |
| 82040 | <1% | 787 | $2K | |
| 73630 | <1% | 142 | $1K | |
| 83880 | <1% | 44 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 166 | $908.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 13 | $798.72 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 103 | $604.00 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 38 | $585.16 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 27 | $579.52 |
| 87040 | <1% | 46 | $504.00 | |
| 87420 | <1% | 103 | $483.24 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 25 | $382.64 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 25 | $382.64 |
| 73502 | <1% | 13 | $326.78 | |
| 73562 | <1% | 18 | $289.09 | |
| 73110 | <1% | 37 | $281.75 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 14 | $258.09 |
| 73130 | <1% | 28 | $253.00 | |
| 96376 | <1% | 113 | $108.00 | |
| 87077 | <1% | 17 | $85.20 | |
| 80305 | <1% | 14 | $71.82 | |
| 90715 | 0% | 83 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOHNSON, TINA (SR MED STAFF AND PROVIDER ENROLLMEN)
| Provider | Location | Paid |
|---|---|---|
| Emerus BHS Sa Thousand Oaks, LLC | San Antonio, TX | $24.94M |
| Ebd Bemc Burleson, LLC | Burleson, TX | $2.07M |
| Ahn Emerus Westmoreland LLC | Greensburg, PA | $1.57M |
| CR Emergency Room LLC | Aubrey, TX | $1.16M |
| Ahn Emerus Westmoreland LLC | Pittsburgh, PA | $903K |
| Ahn Emerus Westmoreland LLC | Pittsburg, PA | $139K |
| 6 C'S to Success LLC | La Crosse, VA | $108K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.